Loading...

SunLink Health Systems, Inc.

SSY•AMEX
HealthcareMedical - Pharmaceuticals
$0.86
$0.004(0.41%)

SunLink Health Systems, Inc. (SSY) Stock Overview

Explore SunLink Health Systems, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-32.34%
↓ 32.34%
Profit Growth
$0.24
↑ 14.93%
EPS Growth
$0.24
↓ 26.92%
Operating Margin
-11.29%
↓ 3.83%
ROE
11.72%
↑ 14.93%
Dividend Yield
0.00%
Analyst Recommendations data is not available for SSYAnalyst Recommendations details for SSY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.

CEO

Mr. Robert M. Thornton Jr.

Employees

1,376

Headquarters

900 Circle 75 Parkway, Atlanta, GA

Founded

1980

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.